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Abstract 
The synthesis of two tetrafluorinated 4-aminosugars, 4-amino-2,3,4-trideoxy-2,2,3,3-tetrafluoro-
D-erythro-hexopyranose hydrochloride (7•HCl) and 4-amino-2,3,4-trideoxy-2,2,3,3-tetrafluoro-D-
threo-hexopyranose hydrochloride (8•HCl), is described. The amino group in α-position of a 
CF2(CF2) group is proposed as a mimic for the hydrogen bond accepting capacity of an alcohol 
group in an unfluorinated sugar. The synthesis of the two sugars was achieved in 4 steps each 
from the sulfinylimine diastereoisomers of D-glyceraldehyde. 
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1. Introduction 
Fluorination of carbohydrates is a popular strategy to investigate carbohydrate binding 
epitopes[1] and enzyme mechanism,[2] or to stabilize glycosidic bonds,[2,3] and indeed a vast 
number of fluorinated carbohydrates and their glycosides have been synthesized for these 
purposes.[4] While the replacement of CHOH with CHF (or CF2) has as main consequence that 
the hydrogen bond donating capacity at that position is lost, the electronic properties of the 
remaining hydroxyl groups can also undergo substantial changes. With respect to protein 
binding, the change in hydrogen bond donating and accepting properties of these alcohol 
groups could have significant additional effects. While these properties are influenced by the 
fluorine electronegativity,  there are other factors that play a role, such as intramolecular 
hydrogen bonding of the OH group with the fluorine atom and hyperconjugation effects, both of 
which depend on relative stereochemistry.[5]  
With regard to alcohol hydrogen bond acceptor capacity, it is instructive to compare a relevant 
parameter, pKBHX, which refers to the equilibrium of the acceptor with a standard hydrogen bond 
donor (p-fluorophenol).[6] Clearly, the hydrogen bond acceptor capacity of the alcohol group in 
trifluoroethanol 2 is reduced compared to that of ethanol 1 to such an extent that it cannot be 
considered a hydrogen bond acceptor any more (Table 1). A similar decrease is seen by 
comparing ethylamine 3 and 2,2,2-trifluoroethylamine 4. Nevertheless, the pKBHX value for 4 is 
relatively close to that of 1, so it can be proposed that a β-trifluorinated (or difluorinated) amine 
is a reasonable mimic for a regular alcohol, if hydrogen bond acceptor properties are 
concerned. 
 
Table 1. Influence of trifluoromethylation on alcohol and amine hydrogen bond acceptor 
capacity. 	   pKBHX	   	   	   pKBHX	  
CH3CH2OH (1) 1.02  CH3CH2NH2 (3) 2.17 
CF3CH2OH (2) -0.28  CF3CH2NH2 (4) 0.71 
  
The design of carbohydrate-based analogues with greater affinity to carbohydrate-processing 
proteins is of interest for use as probes or therapeutics.[7] We have an interest in investigating 
polyfluorination of carbohydrates as a strategy for increasing the typically low protein-
carbohydrate binding affinities. Polyfluorination introduces a hydrophobic moiety, thus causing 
beneficial hydrophobic desolvation upon binding,[8] yet the individual polar C–F bonds retain the 
capacity for attractive interactions with electropositive protein residues.[9] The combination of 
these effects has been coined “polar hydrophobicity”.[10] In order to retain chiral alcohol groups 
in the carbohydrate ring, which were deemed important for binding selectivity, we have focused 
on the synthesis of sugars containing a medium-size hydrophobic moiety such as 2,3-dideoxy-
2,2,3,3-tetrafluorinated carbohydrates, including “tetrafluorinated glucose” (2,3-dideoxy-2,2,3,3-
tetrafluoro-D-erythro-hexopyranose) 5 (Figure 1) and –galactose (2,3-dideoxy-2,2,3,3-
tetrafluoro-D-threo-hexopyranose) 6.[11] It was shown that these structures retain the 
conventional carbohydrate shape,[12] and 6 was found to be a weak substrate of the enzyme 
galactose oxidase.[13] A successful inhibitor of the mycobacterial enzyme UDP-Gal mutase, 
based on a tetrafluorinated galactofuranose sugar, has been recently reported.[14]  
 
 
Figure 1. Tetrafluorinated sugars with the proposed aminosugar analogues. 
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 With the above discussion in mind, the hydrogen bond acceptor capacity of the 4-OH groups in 
5 and 6 will be very low, and hence the corresponding tetrafluorinated aminosugars 7, a glucose 
analogue, and 8, a galactose analogue, became a focus for their synthesis and investigations. 
In addition, a further interest in their synthesis stems from the known interesting biological 
activities of aminosugars and their derivatives,[15] with only a small number of fluorinated 
aminosugar derivatives reported.[16]   
Herein we report the synthesis of 7 and 8. 
 
2. Results and discussion 
The synthesis of the 4-aminosugars was envisaged by reaction of the lithiated fluorinated 
building block B with a chiral glyceraldehyde derived sulfinylimine A. The absolute configuration 
of the auxiliary was expected to control the configuration of the newly formed chiral centre.[17,18] 
The corresponding reactants 9/10 and 11 are known[18] or commercially available. After the 
addition reaction, diol deprotection and alkene ozonolysis would give the fluorinated 
aminosugar.  
 
Scheme 1. Retrosynthetic analysis 
 
The plan benefitted from important literature precedence, in that Konno had not only 
demonstrated that reagent B could be formed and cleanly reacted with electrophiles, but that it 
also reacted with the sulfinylimine derived from benzaldehyde (a 9:1 diastereomeric ratio was 
reported).[19] The ozonolysis/pyranose ring formation had also been demonstrated in an efficient 
synthesis of 2,3-dideoxy-2,2,3,3-tetrafluorinated glucose 5 and galactose 6 by the same 
group.[20]  
The synthesis of 7 is shown in Scheme 2. Following Konno’s conditions, using the (S)-
configured sulfinylimine auxiliary, a 78% yield was achieved for the coupling reaction as a 92:8 
mixture of diastereoisomers. However, under these conditions, the limiting reagent is 
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bromotetrafluorobutene 11, with no less than 2.4 equiv of sulfinylimine used. Given 3 steps are 
used to obtain the sulfinylimines, we chose to reduce the relative amount of this substrate, in 
order to increase the isolated quantity of adducts 12/13. Hence, reducing the number of 
equivalents of 9 to 1.2, a reduced 61% (isolated) yield was obtained for 12/13, in a 4:96 ratio of 
diastereoisomers, but in a larger absolute quantity than would have been obtained under 
Konno’s conditions. Interestingly, under these modified conditions the formation of a minor 
byproduct was observed which, despite isolation in pure form was not possible, could be 
assigned as 14 (~3%, Scheme 3). The presence of the terminal methyl group and the alkene C–
H were clearly observed in the 1H NMR spectrum, and the 3JH-F value of 36.5 Hz indicated a Z-
substituted fluoroalkene. The 19F NMR spectrum showed three resonances, including one 
geminal CF2 group as obvious from a large coupling constant. This type of byproduct, not 
reported by Konno, presumably arose from nucleophilic attack of MeLi to the alkene moiety in 
12/13 via SN2’ fashion as shown.[21]  
 
Scheme 2. Synthesis of the glucose analogue 7.  
 
 
Scheme 3. Proposed identity and formation of the byproduct 14. 
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High-yielding acetonide hydrolysis allowed separation of the diastereoisomers, leading to the 
desired product as a single diastereoisomer 16 in 88% isolated yield. Ozonolysis and amine 
auxiliary removal gave the 4-deoxy-4-amino glucose derivative 7 in high yield, as the 
hydrochloric acid salt. Interestingly, the precipitated salt was obtained as pure α anomer. 
The similar synthesis of the corresponding galactose isomer is shown in Scheme 3. Now the 
(R)-configured sulfinylimine auxiliary is used for the reaction with lithiated 1,1,2,2-
tetrafluorobutene, leading to a separable mixture of adducts 18 and 19. The MeLi SN2’ adduct 
was again observed as minor isomer (not shown). Diol deprotection and ozonolysis led to the 
pyranose 21 in excellent yield. The removal of the auxiliary proved cumbersome, in that for this 
compound, precipitation as the hydrochloride salt was not possible. This resulted in an 
incomplete separation from the sulfinate ester byproduct. Any attempt of purification by 
chromatography proved unsuccessful, leading to a complex mixture. Protection of the 4-amino 
and 6-hydroxy groups as Cbz allowed the purification but subsequent hydrogenolysis resulted in 
obtaining a similar complex mixture. As methyl tert-butanesulfinate is somewhat volatile (52 
°C/16 torr), purification was attempted by co-evaporating with MeOH carefully keeping the 
temperature below 40 °C to avoid apparition of impurities. This proved only partially successful, 
but after dissolving the salt in water, the impurity could largely be removed by extraction with 
Et2O. Hence, 8•HCl was obtained in excellent yield.  
 
Scheme 3. Synthesis of the galactose analogue 8. 
 
The relative stereochemistry of the obtained products could be deduced from X-ray 
crystallographic analysis of 17 (Figure 2). With the SS-configuration of the auxiliary and the C5 
configuration from the starting material retained in the product, the gluco configuration at C4 is 
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Deleted: , which unfortunately did not 
yield suitable crystals for X-ray diffraction 
analysis
evident, as is the 4C1 conformation. This was also confirmed in solution by 13C NMR analysis, in 
that the 2JC4-F values were 19 Hz for both fluorine atoms (for both anomers), indicating that the 
electronegative substituent at the 4-position is equatorial.[22] While we have not been able to 
crystallise 21, a similar NMR analysis showed 2JC4-F values of around 30 and 19 Hz (for both 
anomers), indicating an axial electronegative substituent at C4. The 13C NMR of the fully 
deprotected aminosugars 7 and 8 showed similar values.  
  
Figure 2.  X-ray crystallographic analysis of β-17. 
 
The 2JC4-F values mentioned above for both the gluco and galacto configured structures also 
indicated that they existed in the pyranose form in solution. This was unambiguously shown by 
HMBC analysis of the aminosugars 7 and 8 (see supporting information). Irradiation of the 
anomeric proton led to a cross peak to C5 (and not to C4, which would represent the possible 
iminosugar isomer).  
Interestingly, 7•HCl solidified as the pure α-anomer, though no crystals suitable for X-ray 
crystallography could be obtained. The anomeric equilibrium in CD3OD consisted of a 75:25 α/β 
mixture of anomers. The anomeric equilibrium for the galacto configured 8•HCl in CD3OD was 
54:46 α/β. 
The observed stereochemical outcome of the addition reactions to give 12/13 and 18/19 clearly 
demonstrated that the absolute configuration of the sulfinylimine auxiliary determined the 
stereochemical course of the reaction. The formation of the major isomers is consistent with an 
open transition state as shown in Figure 3 (left).[23] The difference in stereoselectivity of the 
addition of 11 to 9 or 10 can be explained by the additional influence of the glyceraldehyde 
stereogenic centre.  
 Figure 3. Explanation for the diastereoselectivity of the addition reactions. 
 
According to the Cornforth-Evans model of stereoselection[24] (or the polar Felkin Anh model,[25] 
not shown), the S-glyceraldehyde configuration induces Si-face attack (Figure 3, right). This is 
also the imine face that the S-configured sulfinylimine auxiliary makes available for reaction, 
according to the open transition state shown. Hence, in the (S,SS) combination (9), both 
stereoelements lead to a matched stereoinduction, resulting in a 96:4 ratio of products. In 
contrast, the stereoinduction in the (S,RS) combination (10) shows a mismatch, leading to a 
reduced 88:12 ratio of products.[26] 
 
3. Conclusion 
The β,β-difluorinated amino moiety is proposed as a mimic for alcohol groups with regard to 
hydrogen bond accepting capacity. This led to tetrafluorinated aminosugars 7 and 8 as 
analogues of interest in the context of our investigations involving polyfluorinated carbohydrates. 
A short synthesis of these aminosugars is described with the addition of a lithiated 
tetrafluorobutene building block to a glyceraldehyde sulfinylimine as key step.  
 
4. Experimental  
4.1 (2S,3S,SS)-1,2-Isopropylidenedioxy-3-(tert-butylsulfinylamino)-4,4,5,5-tetrafluorohept-6-ene 
(12) and (2S,3R,SS)-1,2-isopropylidenedioxy-3-(tert-butylsulfinylamino)-4,4,5,5-tetrafluorohept-
6-ene (13) 
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To a solution of sulfinylimine 9 (2.5 g, 10.7 mmol, 1.2 equiv) in THF (40 mL) at –78 °C was 
added bromotetrafluorobutene 11 (1.14 mL, 8.93 mmol, 1.0 equiv). After 10 min, MeLi (1.6 M in 
Et2O, 13.4 mL, 21.4 mmol, 2.4 equiv) was added dropwise over 30 min and the reaction mixture 
was stirred for another 1.5 h. The reaction was quenched with saturated NH4Cl aq. (25 mL), 
diluted with H2O (15 mL) and extracted with Et2O (3 × 75 mL). The combined organic layers 
were dried (MgSO4), filtered and concentrated in vacuo to give a crude mixture of 
diastereoisomers (dr 97:3). Purification via column chromatography (petroleum ether/EtOAc 
60:40 to 50:50) afforded 1.96 g (5.43 mmol, 61%) of a mixture of diastereoisomers 12/13 along 
with 0.098 g (0.27 mmol, 3%) of 14 as an off-white solid. Rf 0.23 (petroleum ether 40-60 
°C/EtOAc 60:40). IR (neat) 3219 (w, br), 2985 (m), 1371 (m), 1112 (s), 1056 (s) cm-1. 1H NMR 
(400 MHz, CDCl3) δ 6.14–5.80 (m, 4H, H-7trans+H-6, major and minor), 5.71 (d, 3JHH=10.6 Hz, 
1H, H-7cis, major), 5.70 (d, 3JHH=10.9 Hz, 1H, H-7cis, minor), 4.61–4.54 (m, 2H, H-2, major and 
minor), 4.20–4.08 (m, 1H, H-3, major), 4.08–3.99 (m, 3H, H-1a+b, major and H-1a, minor), 3.95 
(d, 3JHH=10.2 Hz, 1H, NH, minor), 3.78 (dd, 2JHH=8.2, 3JHH=6.1 Hz, 1H, H-1b, minor), 3.82–3.70 
(m, 1H, H-3, minor), 3.68 (d, 3JHH=5.4 Hz, 1H, NH, major), 1.55 (s, 3H, CH3,iPr, major), 1.45 (s, 
3H, CH3,iPr, minor), 1.32 (s, 6H, CH3,iPr, major and minor), 1.24 (s, 9H, CH3,tBu, minor), 1.22 (s, 
9H, CH3,tBu, major) ppm. 13C NMR (101 MHz, CDCl3) δ 126.4 (t, 2JCF=24.2 Hz, C-6, minor), 
126.0 (t, 2JCF=24.2 Hz, C-6, major), 124.5 (t, 3JCF=9.5 Hz, C-7, major), 124.3 (t, 3JCF=9.5 Hz, C-
7, minor), 115.9 (tt, 1JCF=256.1, 2JCF=36.6 Hz, CF2, major), 115.5 (tt, 1JCF=248.8, 2JCF=35.1 Hz, 
CF2, major), 110.1 (Cq,iPr, minor), 109.7 (Cq,iPr, major), 72.7 (C-2, minor), 72.6 (C-2, major), 66.5 
(C-1, minor), 64.6 (d, 4JCF=4.4 Hz, C-1, major), 58.4 (t, 2JCF=23.4 Hz, C-3, minor), 57.8 (t, 
2JCF=21.3 Hz, C-3, major), 57.6 (Cq,tBu, minor), 56.7 (Cq,tBu, major), 26.2 (CH3,iPr, minor), 25.8 
(CH3,iPr, major), 24.34 (CH3,iPr, major), 24.25 (CH3,iPr, minor), 22.5 (CH3,tBu, minor), 22.3 (CH3,tBu, 
major) ppm (2 × CF2, minor not visible). 19F NMR (282 MHz, CDCl3) δ –109.8 (dd, 2JFF=279.2, 
J=8.6 Hz, 1F, minor), –111.8 – –112.8 (m, 1F, major), –112.4 – –113.5 (m, 1F, major), –113.1 – 
–114.2 (m, 1F, major), –118. 7 (ddd, 2JFF=279.4, J=17.2, 3JFF=4.4 Hz, 1F, minor), –120.1 (app. 
ddt, 2JFF=281.5, J=16.1, 7.5 Hz, 1F, major) ppm (2 × F, minor overlap with major). MS (ESI+) 
(m/z) 425 (M+Na+MeCN)+. HRMS (MS+) for C14H23F4NNaO3S (M + Na)+ calcd 384.1227, found 
384.1233.  
Selected data for the MeLi SN2’ byproduct (2S,3R,SS,Z)-1,2-Isopropylidenedioxy-3-(tert-
butylsulfinylamino)-4,4,5-trifluorooct-5-ene (14): 1H NMR (400 MHz, CDCl3) δ 5.47 (dt, 
3JHF,trans=36.5, 3JHH=7.6 Hz, 1H, H-6), 2.28–2.15 (m, 2H, H-7), 1.03 (t, 3JHH=7.5 Hz, 3H, H-8) 
ppm. 13C NMR (101 MHz, CDCl3) δ 16.8 (d, 4JCF=4.4 Hz, C-7), 13.1 (s, C-8) ppm. 19F NMR (376 
MHz, CDCl3) δ –108.1 (dddt, 2JFF=265.0, 3JFF=14.8, J=10.8, 2.2 Hz, 1F, F-4), –110.8 (app. dt, 
2JFF=265.0, J=13.3 Hz, 1F, F-4’), –132.0 – –132.2 (m, 1F, F-5) ppm. MS (ESI+) (m/z) 358 
(M+H)+. HRMS (MS+) for C15H27F3NO3S (M + H)+ calcd 358.1658, found 358.1663. The C3 
stereochemistry is assumed. 
4.2 (2S,3S,SS)-3-(tert-Butylsulfinylamino)-4,4,5,5-tetrafluorohept-6-ene-1,2-diol (15) and 
(2S,3R,SS)- 3-(tert-butylsulfinylamino)-4,4,5,5-tetrafluorohept-6-ene-1,2-diol (16) 
  
The 4:96 mixture of 12/13 (2.06 g, 5.70 mmol, 1 equiv) was dissolved in MeOH (60 mL). PTSA 
(196 mg, 1.14 mmol, 0.2 equiv) was added, and the solution stirred for 23 h, and then quenched 
with sat. aq. NaHCO3 (30 mL). H2O (30 mL) was added and the mixture was extracted with 
EtOAc (3 × 120 mL). The combined organic layers were washed with H2O (10 mL), dried 
(Na2SO4), filtered and concentrated. Purification via column chromatography (petroleum 
ether/acetone 70:30 to 50:50) afforded 1.607 g (5.00 mmol, 88%) of the pure major 
diasteroisomer 16 as a yellow syrup. Rf 0.51 (petroleum ether 40-60 °C/acetone 60:40). [α]D 
+68.3 (c 0.204, CHCl3, 25 °C). IR (neat) 3362 (m, br), 3243 (m, br), 2962 (w), 1102 (s), 1068 (s), 
1039 (s) cm-1. 1H NMR (400 MHz, CDCl3) δ 6.12–5.83 (m, 2H, H-6+H-7trans), 5.73 (d, 3JHH=10.6 
Hz, 1H, H-7cis), 5.57 (d, 3JHH=9.5 Hz, 1H, NH), 4.83 (d, 3JHH=10.3 Hz, 1H, OH-2), 4.21–4.07 (m, 
1H, H-3), 4.07–3.91 (m, 3H, H-1a+b, H-2), 3.48–3.35 (m, 1H, OH-1), 1.27 (s, 9H, CH3,tBu) ppm. 
13C NMR (101 MHz, CDCl3) δ 126.3 (t, 2JCF=24.4 Hz, C-6), 124.3 (t, 3JCF=9.5 Hz, C-7), 66.1 (C-
2), 65.0 (C-1), 62.8 (t, 2JCF=22.6 Hz, C-3), 56.7 (Cq,tBu), 22.6 (CH3,tBu) ppm (2 × CF2 not visible). 
19F NMR (376 MHz, CDCl3) δ –112.7 (dd, 2JFF=264.0, JHF=11.3 Hz, 1F), –113.9 (dd, 2JFF=264.0, 
JHF=11.3 Hz, 1F), –118.9 (dd, 2JFF=277.4, JHF=13.0 Hz, 1F), –119.7 (dd, 2JFF=277.4, JHF=15.6 
Hz, 1F) ppm. MS (ESI+) (m/z) 385 (M+Na+MeCN)+. HRMS (MS+) for C11H19F4NNaO3S (M + 
Na)+ calcd 344.0914, found 344.0915.  
A sample was purified by HPLC to obtain the minor isomer 15 in pure form (hexane/acetone 
70:30). Rf 0.31 (petroleum ether 40-60 °C/acetone 60:40). [α]D –0.866 (c 0.289, CHCl3, 25 °C). 
IR (neat) 3368 (m), 3280 (m), 1107 (s), 1053 (s), 1036 (s) cm-1. 1H NMR (400MHz, CDCl3) δ 
6.13–5.98 (m, 1H, H-6), 5.94–5.87 (m, 1H, H-7trans), 5.74 (d, 3JHH=10.9 Hz, 1H, H-7cis), 4.36 (d, 
3JHH=9.0 Hz, 1H, NH), 4.28 (qd, J=5.8, 2.9 Hz, 1H, H-2), 4.08–3.96 (m, 1H, H-3), 3.71 (dd, 
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2JHH=11.6, 3JHH=6.0 Hz, 1H, H-1a), 3.65 (dd, 2JHH=11.6, 3JHH=6.4 Hz, 1H, H-1b), 3.13 (d, 3JHH=5.3 
Hz, 1H, OH-2), 3.02 (t, 3JHH=6.6 Hz, 1H, OH-1), 1.26 ppm (s, 9H, CH3,tBu) ppm. 13C NMR (101 
MHz, CDCl3) δ 126.3 (t, 2JCF=24.5 Hz, C-6), 124.4 (t, 3JCF=9.5 Hz, C-7), 115.8 (tt, 1JCF=249.6, 
2JCF=35.9 Hz, CF2), 116.7 (tt, 1JCF=256.1, 2JCF=35.5 Hz, CF2), 68.6 (C-2), 63.1 (C-1), 57.7 
(Cq,tBu), 54.7 (t, 2JCF=22.7 Hz, C-3), 22.4 (CH3,tBu) ppm. 19F NMR (282 MHz, CDCl3) δ –110.4 (dd, 
1JFF=279.4, J=10.7 Hz, 1F, CFF), –112.7 (d, J=11.8 Hz, 2F, CF2), –117.0 (dd, 1JFF=279.4, 
J=16.1 Hz, 1F, CFF) ppm.  
4.3 (SS)-4-(tert-Butylsulfinylamino)-2,3,4-trideoxy-2,2,3,3-tetrafluoro-D-erythro-hexopyranose 
(17) 
  
Ozone was bubbled through a solution of 16 (1.60 g, 4.98 mmol) in MeOH (50 mL) until TLC 
showed complete consumption of the starting material (15 min). O2 was bubbled through to 
remove excess ozone (10 min) and then, Me2S (1.83 mL, 24.9 mmol, 5 equiv) was added and 
the reaction mixture was allowed to warm to rt and concentrated to afford 1.56 g (4.83 mmol, 
97%) of the pure aminosugar derivative 17, which solidified as the pure β–anomer. At 
equilibrium in CD3OD, a 60:40 α/β mixture of anomers is obtained. Rf 0.23 (petroleum ether 40-
60 °C/acetone 60:40). [α]D +97.6 (c 0.469, CH3OH, 26 °C, at anomeric equilibrium). IR (neat) 
3245 (m), 2985 (w), 1303 (m), 1151 (m), 1037 (s) cm-1. 1H NMR (400 MHz, CD3OD) δ 5.23 (dd, 
3JHF=7.8, 5.5 Hz, 1H, H-1α), 4.90 (dd, 3JHF=15.5, JHF=2.9 Hz, 1H, H-1β), 4.29–4.18 (m, 1H, H-
5α), 3.98–3.76 (m, 6H, H-4α, H-4β, 2 × H-6α, 2 × H-6β), 3.76–3.69 (m, 1H, H-5β), 1.26 (s, 18H, 
CH3,tBu,α+ CH3,tBu,β) ppm. 13C NMR (101 MHz, CD3OD) δ 92.9 (ddd, 2JCF=26.4, 2JCF=19.4, 
3JCF=2.6 Hz, C-1β), 92.8 (dd, 2JCF=36.6, 2JCF=26.3 Hz, C-1α), 75.2 (d, JCF=2.9 Hz, C-5β), 70.6 
(d, JCF=4.4 Hz, C-5α), 61.4 (C-6β), 61.3 (C-6α), 59.2 (t, 2JCF=18.7 Hz, C-4β), 59.0 (t, 2JCF=17.6 
Hz, C-4α), 58.6 (2×Cq,tBu), 23.2 (CH3,tBu,α), 23.2 (CH3,tBu,β) ppm (2 × CF2, α + β not visible). 19F 
NMR (376 MHz, CD3OD) δ –121.3 – –122.3 (m, 1F, Fα), –125.2 (dddd, 2JFF=258.4, J=21.7, 
15.6, 6.9 Hz, 1F, Fα), –125.9 – –126.8 (m, 1F, Fα), –128.2 (dt, 2JFF=259.2, J=16.5 Hz, 1F, Fβ), 
–129.1 (dq, 2JFF=259.2, J=10.4 Hz, 1F, Fβ), –135.8 (ddd, 2JFF=265.3, J=15.2, 11.7 Hz, 1F, Fα), 
–138.5 (dt, 2JFF=257.5, 12.6 Hz, 1F, Fβ), –140.8 – –141.7 (m, 1F, Fβ) ppm. MS (ESI+) (m/z) 387 
(M+Na+MeCN)+. HRMS (MS+) for C10H17F4NNaO4S (M + Na)+ calcd 346.0707, found 346.0706. 
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4.4 4-Amino-2,3,4-trideoxy-2,2,3,3-tetrafluoro-D-erythro-hexopyranose hydrochloride (7•HCl) 
  
A solution of 17 (700 mg, 2.17 mmol, 1 equiv) in MeOH (1.65 mL) and 4M HCl in dioxane (1.1 
mL, 4.33 mmol, 2 equiv) was stirred at rt for 1 h then evaporated in vacuo to near dryness. Et2O 
(10 mL) was added in order to precipitate the hydrochloride salt and the supernatant was 
removed. The solid was washed once more with Et2O (10 mL) then dried under vacuum to yield 
525 mg (2.05 mmol, 95%) of the 7•HCl as a white solid consisting only of α-anomer. At 
equilibrium in CD3OD, a 75:25 α/β mixture of anomers is obtained. [α]D +52.7 (c 0.430, CH3OH, 
26 °C, at anomeric equilibrium). IR (neat) 3343 (m, br), 2888 (m, br), 1153 (s), 1111 (s), 1059 
(s) cm-1. Data for the α anomer: 1H NMR (400 MHz, CD3OD) δ 5.33 (dd, JHF=7.3, 4.3 Hz, 1H, H-
1), 4.38 (dt, J=10.3, 3.5 Hz, 1H, H-5), 4.07–3.93 (m, 1H, H-4), 3.85 (dd, 2JHH=12.5, 3JHH=4.3 Hz, 
1H, H-6a), 3.80 (dd, 2JHH=12.5, 3JHH=3.7 Hz, 1H, H-6b) ppm. 13C NMR (101 MHz, CD3OD) δ 
117.9–108.8 (2 × CF2), 92.6 (dd, 2JCF=35.6, 26.0 Hz, C-1), 67.9 (d, JCF=2.2 Hz, C-5), 61.7 (C-6), 
52.5 (t, 2JCF=19.1 Hz, C-4) ppm. 19F NMR (376 MHz, CD3OD) δ –121.4 – –122.5 (m, 1F), –124.0 
– –125.8 (m, 2F), –137.1 (dt, 2JFF=267.6, J=12.4 Hz, 1F) ppm. Unambiguous resonances for the 
β anomer: 1H NMR (400 MHz, CD3OD) δ 5.06 (d, JHF=14.3 Hz, 1H, H-1). 13C NMR (101 MHz, 
CD3OD) δ 72.4 (s, C-5), 61.8 (s, C-6). 19F NMR (376 MHz, CD3OD) δ –127.8 (t, J=12.1 Hz, 2F), 
–139.6 (dt, 2JFF=260.1, J=11.3 Hz, 1F), –140.8 (dd, 2JFF=260.1, J=13.9 Hz, 1F) ppm. MS (ESI+) 
(m/z) 261 (M+H+MeCN)+. HRMS (MS+) for C6H10F4NO3 (M + H)+ calcd 220.0591, found 
220.0590.  
4.5 (2S,3S,RS)-1,2-Isopropylidenedioxy-3-(tert-butylsulfinylamino)-4,4,5,5-tetrafluorohept-6-ene 
(18) 
  
To a solution of sulfinylimine 10 (0.52 g, 2.23 mmol, 1.2 equiv) in THF at –78 °C was added 
bromotetrafluorobutene (0.236 mL, 1.86 mmol, 1.0 equiv). After 10 min, MeLi (1.6 M in Et2O, 2.8 
mL, 4.46 mmol, 2.4 equiv) was added over 45 min and the reaction mixture was stirred for 
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another 1.5 h. The reaction was quenched with saturated NH4Cl aq. (10 mL) and extracted with 
Et2O (3 × 30 mL). The combined organic layers were dried (MgSO4), filtered and concentrated 
in vacuo to give a crude mixture of diastereoisomers 18 and 19 (dr 88:12). Purification via 
column chromatography (petroleum ether/EtOAc 75:25) afforded 442 mg (1.22 mmol, 66%) of 
pure 18 as a white solid. Rf 0.29 (petroleum Ether 40-60 °C/EtOAc 70:30). [α]D –77.6 (c 0.502, 
CHCl3, 19 °C). IR (neat) 3347 (w), 2982 (w), 1189 (m), 1109 (s), 1073 (s) cm-1. 1H NMR (400 
MHz, CDCl3) δ 5.98 (ddd, 3JHF=22.6, 3JHH,trans=17.3, 3JHH,cis=10.9 Hz, 1H, H-6), 5.90–5.81 (m, 1H, 
H-7trans), 5.69 (d, 3JHH,cis=10.9 Hz, 1H, H-7cis), 4.54 (t, J=6.9 Hz, 1H, H-2), 4.31 (d, J=7.3 Hz, 1H, 
NH), 4.17 (app. t, J=8.2 Hz, 1H, H-1a), 4.07 (dd, 2JHH=8.5, 3JHH=6.7 Hz, 1H, H-1b), 3.82 (td, 
J=12.9, 7.6 Hz, 1H, H-3), 1.46 (s, 3H, CH3,iPr), 1.37 (s, 3H, CH3,iPr), 1.25 ppm (s, 9H, CH3,tBu) 
ppm. 13C NMR (101 MHz, CDCl3) δ 126.5 (t, 2JCF=24.2 Hz, C-6), 124.0 (t, 3JCF=9.5 Hz, C-7), 
115.7 (tt, 1JCF=256.1, 2JCF=35.1 Hz, CF2), 115.5 (tt, 1JCF=250.3, 2JCF=35.1 Hz, CF2), 110.2 
(Cq,iPr), 71.3 (C-5), 66.2 (C-1), 56.7 (Cq,tBu), 56.1 (t, 2JCF=23.4 Hz, C-3), 26.2 (CH3,iPr), 25.3 
(CH3,iPr), 22.6 (CH3,tBu) ppm. 19F NMR (376 MHz, CDCl3) δ –112.3 (dd, 2JFF=265.3, J=11.3 Hz, 
1F), –113.1 (dd, 2JFF=265.3, J=11.3 Hz, 1F), –117.2 (dd, 2JFF=277.4, J=13.9 Hz, 1F), –118.3 
(ddd, 2JFF=277.4, J=12.1, 3.5 Hz, 1F) ppm. MS (ESI+) (m/z) 425 (M+Na+MeCN)+. HRMS (MS+) 
for C14H23F4NNaO3S (M + Na)+ calcd 384.1227, found 384.1230.  
The minor isomer (2S,3R,RS)-1,2-Isopropylidenedioxy-3-(tert-butylsulfinylamino)-4,4,5,5-
tetrafluorohept-6-ene 19 could be isolated along with the MeLi SN2’ byproduct and some 
unknown impurity (53 mg, 76:9:15 ratio). Selected characterization data: Rf 0.17 (petroleum 
ether 40-60 °C/EtOAc 70:30). 1H NMR (400MHz, CDCl3) δ 6.14–5.98 (m, 1H, H-6), 5.93–5.85 
(m, 3JHH,trans=17.5 Hz, 1H, H-7trans), 5.73 (d, 3JHH,cis=10.9 Hz, 1H, H-7cis), 4.50–4.43 (m, 1H, H-2), 
4.24–4.12 (m, 1H, H-3), 3.98 (app. t, J=7.5 Hz, 1H, H-1a), 3.79 (app. t, J=7.8 Hz, 1H, H-1b), 3.73 
(d, 3JHH=7.6 Hz, 1H, NH), 1.40 (s, 3H, CH3,iPr), 1.32 (s, 3H, CH3,iPr), 1.24 (s, 9H, CH3,tBu) ppm. 13C 
NMR (101 MHz, CDCl3) δ 125.9 (t, 2JCF=24.2 Hz, C-6), 124.9 (t, 3JCF=9.5 Hz, C-7), 115.7 (tt, 
1JCF=256.4, 2JCF=35.6 Hz, CF2), 115.6 (tt, 1JCF=249.4, 2JCF=33.7 Hz, CF2), 109.0 (Cq,iPr), 73.3 (C-
2), 64.8 (C-1), 57.5 (t, 2JCF=23.1 Hz, C-3), 57.0 (Cq,tBu), 26.0 (CH3,iPr), 24.6 (CH3,iPr), 22.5 
(CH3,tBu) ppm. 19F NMR (376 MHz, CDCl3) δ –111.3 (m, 2JFF=264.9 Hz, 1F), –113.3 (ddt, 
2JFF=264.9, J=12.1, 6.5 Hz, 1F), –114.6 (ddt, 2JFF=278.5, J=12.6, 5.6 Hz, 1F), –117.4 (ddt, 
2JFF=278.5, J=14.5, 6.1 Hz, 1F) ppm.  
Selected data for the MeLi SN2’ byproduct (2S,3S,RS,Z)-1,2-Isopropylidenedioxy-3-(tert-
butylsulfinylamino)-4,4,5-trifluorooct-5-ene: 1H NMR (400 MHz, CDCl3) δ 
5.42 (dt, 3JHF,trans=35.9, 3JHH=7.6 Hz, 1H, H-6), 2.28–2.15 (m, 2H, H-7), 1.05 
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(t, 3JHH=7.5 Hz, 3H, H-8) ppm. 13C NMR (101 MHz, CDCl3) δ 16.7 (d, 4JCF=4.0 Hz, C-7), 13.0 (C-
8) ppm. 19F NMR (376 MHz, CDCl3) δ –107.2 (app. dt, 2JFF=264.4, J=13.9 Hz, 1F, F-4), –112.8 
(app. dt, 2JFF=264.4, J=13.9 Hz, 1F, F-4’), –130.8 (app. dt, 3JHF,trans=35.5, J=14.7 Hz, 1F, F-3) 
ppm. The stereochemistry at C3 is presumed.  
4.6 (RS)-4-(tert-Butylsulfinylamino)-2,3,4-trideoxy-2,2,3,3-tetrafluoro-D-threo-hexopyranose (21) 
 
A mixture of sulfinamine 18 (435 mg, 1.20 mmol, 1 equiv) and PTSA (41 mg, 0.24 mmol, 0.2 
equiv) in MeOH (10 mL) was stirred for 13.5 h then quenched with sat. aq. NaHCO3 (3 mL). H2O 
(12 mL) was added and the mixture was extracted with EtOAc (3 × 30 mL). The combined 
organic layers were washed with H2O (10 mL), dried (Na2SO4), filtered and concentrated to 
afford 383 mg of the crude product 20. The latter was dissolved in MeOH (15 mL) and ozone 
was bubbled through the solution until blue colour appeared (15 min). O2 was bubbled through 
to remove excess ozone (10 min) and then, Me2S (0.44 mL, 6.0 mmol, 5 equiv) was added and 
the reaction mixture was allowed to warm to rt and concentrated. Purification via column 
chromatography (petroleum ether/acetone 70:30 to 60:40) afforded 348 mg (1.01 mmol, 89%) of 
the pure aminosugar derivative 21, as a white solid enriched in β-anomer. At equilibrium in both 
acetone-d6 and CD3OD, a 50:50 α/β mixture of anomers was obtained. Rf 0.19 (petroleum ether 
40-60 °C/acetone 60:40). [α]D +20.0 (c 0.627, CH3OH, 26 °C, at anomeric equilibrium). IR (neat) 
3487 (w), 3287 (m), 2975 (w), 1041 (s), 1005 (s) cm-1. 1H NMR (400 MHz, acetone-d6) δ 5.36 
(dd, J=9.3, 6.4 Hz, 1H, H-1α), 5.11 (ddd, J=14.7, 3.9, 0.7 Hz, 1H, H-1β), 4.61–4.53 (m, 1H, H-
5α), 4.51–4.41 (m, 2H, NHα, NHβ), 4.35–4.16 (m, 2H, 2×OH-6), 4.16–4.03 (m, 3H, H-4α, H-4β, 
H-5β), 3.82–3.64 (m, 4H, 2 × H-6α, 2 × H-6β), 1.26 (s, 9H, tBu,β), 1.25 (s, 9H, tBu,α) ppm. 13C 
NMR (101 MHz, acetone-d6) δ 93.2 (ddd, 2JCF=27.1, 19.8, 3JCF=3.7 Hz, C-1β), 92.7 (dd, 
2JCF=36.6, 26.3 Hz, C-1α), 73.6 (d, 3JCF=4.4 Hz, C-5β), 68.4 (d, 3JCF=2.9 Hz, C-5α), 60.5 (C-6α), 
60.2 (C-6β), 59.8 (dd, 2JCF=30.7, 19.0 Hz, C-4α), 59.5 (dd, 2JCF=29.3, 17.6 Hz, C-4β), 57.4 
(Cq,tBu,β), 57.4 (Cq,tBu,α), 22.8 (6×CH3,tBu,α+β) ppm (2×CF2, α + β not visible). 19F NMR (376 
MHz, CD3OD) δ –116.6 (ddtd, 2JFF=260.5, J=15.2, 9.1, 2.2 Hz, Fα), –118.2 (m, 2JFF=261.8 Hz, 
Fβ), –119.1 (dddd, 2JFF=269.6, J=19.5, 9.5, 9.1 Hz, Fα), –126.3 (m, 2JFF=260.5 Hz, Fα), –128.9 
(m, 2JFF=261.8 Hz, Fβ), –134.6 (dddd, 2JFF=269.6, J=16.0, 11.3, 5.2 Hz, Fα), –137.4 (m, 
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2JFF=263.1 Hz, Fβ), –138.5 (dddd, 2JFF=263.1, J=17.8, 14.3, 6.9 Hz, Fβ) ppm. MS (ESI+) (m/z) 
387 (M+Na+MeCN)+. HRMS (MS+) for C10H17F4NNaO4S (M + Na)+ calcd 346.0707, found 
346.0713.  
Analytical sample of the pure diol (2S,3S,RS)-3-(tert-Butylsulfinylamino)-4,4,5,5-tetrafluorohept-
6-ene-1,2-diol (20) was obtained by column chromatography (petroleum ether 
40-60 °C/acetone 70:30). Rf 0.25 (petroleum ether 40-60 °C/acetone 60:40). 
[α]D –44.8 (c 0.532, CHCl3, 21 °C). IR (neat) 3299 (m), 2963 (w), 1237 (m), 
1116 (s), 1028 (s) cm-1. 1H NMR (400 MHz, CD3OD) δ ppm 6.19– 6.03 (m, 
1H, H-6), 5.87 (dt, 3JHH,trans=17.3, 4JHF=2.3 Hz, 1H, H-7trans), 5.77 (d, 3JHH,cis=11.1 Hz, 1H, H-7cis), 
4.15 (dd, 3JHH=8.5, 5.9 Hz, 1H, H-2), 4.03 (t, 3JHF=13.6 Hz, 1H, H-3), 3.62 (dd, 2JHH=10.9, 
3JHH=8.5 Hz, 1H, H-1a), 3.54 (dd, 2JHH=10.9, 3JHH=5.9 Hz, 1H, H-1b), 1.26 (s, 9H). 13C NMR (101 
MHz, CD3OD) δ 128.5 (t, 2JCF=24.2 Hz, C-6), 124.8 (t, 3JCF=9.5 Hz, C-7), 118.1 (tt, 1JCF=255.4, 
2JCF=33.7 Hz, CF2), 117.2 (tt, 1JCF=248.8, 2JCF=34.4 Hz, CF2), 68.4 (C-2), 63.2 (C-1), 58.6 (t, 
2JCF=22.7 Hz, C-3), 58.3 (Cq,tBu), 23.1 (CH3,tBu) ppm. 19F NMR (282 MHz, CD3OD) δ –112.8 (dd, 
2JFF=265.7, 11.8 Hz, 1F), –113.8 (dd, 2JFF=265.7, 10.7 Hz, 1F), –117.2 (dd, 2JFF=274.0, 14.0 Hz, 
1F), –119.3 (dd, 2JFF=274.0, 12.9 Hz, 1F) ppm. MS (ESI+) (m/z) 385 (M+Na+MeCN)+. HRMS 
(MS+) for C11H19F4NNaO3S (M + Na)+ calcd 344.0914, found 344.0909.  
4.7 4-Amino-2,3,4-trideoxy-2,2,3,3-tetrafluoro-D-threo-hexopyranose hydrochloride (8•HCl) 
 
A solution of sulfinamide 21 (190 mg, 0.588 mmol, 1 equiv) in MeOH (1.2 mL) and 4M HCl in 
dioxane (0.60 mL, 2.35 mmol, 4 equiv) was stirred at rt for 0.5 h then evaporated in vacuo. The 
residue was coevaporated with MeOH (10 × 20 mL) then diluted in H2O (15 mL), washed with 
Et2O (2 × 5 mL) and concentrated to afford 153 mg of the amine hydrochloride 8•HCl along with 
less than 3% of impurities as a colourless oil. Anomeric ratio at equilibrium in CD3OD: 54:46 
α/β. Approximated yield >95%. IR (neat) 3210 (m, br), 2886 (m), 1526 (m), 1109 (s), 1029 (s) 
cm-1. 1H NMR (400MHz, CD3OD) δ 5.39 (dd, J=8.5, 7.1 Hz, 1H, H-1α), 5.12 (dd, J=15.0, 3.1 Hz, 
1H, H-1β), 4.66–4.57 (m, 1H, H-5α), 4.34–4.20 (m, 2H, H-4α, H-4β), 4.19–4.10 (m, 1H, H-5β), 
3.96–3.71 ppm (m, 4H, 2 × H-6α, 2 × H-6β) ppm. 13C NMR (101 MHz, CD3OD) δ 117.5–108.7 
(2 × CF2, α+β), 93.5 (ddd, 2JCF=26.4, 19.0, 3JCF=3.4 Hz, C-1β), 92.9 (dd, 2JCF=36.7, 24.9 Hz, C-
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1α), 72.0 (d, JCF=4.4 Hz, C-5β), 66.7 (d, JCF=3.7 Hz, C-5α), 60.9 (C-6α), 60.7 (C-6β), 54.3 (dd, 
2JCF=33.4, 19.4 Hz, C-4α), 53.9 (dd, 2JCF=32.6, 19.4 Hz, C-4β) ppm. 19F NMR (376 MHz, 
CD3OD) δ –116.9 (app. ddt, 2JFF=274.0, J=15.9, 9.2, Hz, Fα), –118.1 – –118.9 (m, Fβ), –119.5 
(ddt, 2JFF=273.8, 3JFF=17.5, 3JFF=8.7, JHF=8.7 Hz, Fα), –125.3 – –126.3 (m, Fα), –127.8 – –128.7 
(m, Fβ), –136.0 (dddd, 2JFF=273.8, 3JFF=16.2, 3JFF=10.3, JHF=4.2 Hz, Fα), –137.9 (app. dtd, 
2JFF=267.5, J=15.4, 6.6 Hz, Fβ), –139.2 (m, 2JFF=267.5 Hz, Fβ) ppm. {1H} 19F NMR (376 MHz, 
CD3OD) δ –116.8 (ddd, 2JFF=274.0, 3JFF=16.1, 3JFF=8.6 Hz, Fα), –118.5 (ddd, 2JFF=275.0, 
3JFF=13.4, 3JFF=6.4 Hz, Fβ), –119.4 (ddd, 2JFF=273.9, 3JFF=17.3, 3JFF=8.5 Hz, Fα), –125.8 (ddd, 
2JFF=274.0, 3JFF=17.3, 3JFF=10.3 Hz, Fα), –128.3 (ddd, 2JFF=275.2, 3JFF=15.6, 3JFF=10.5 Hz, Fβ), 
–136.0 (ddd, 2JFF=273.8, 3JFF=16.1, 3JFF=10.3 Hz, Fα), –138.3 – –137.5 (m, Fβ), –139.2 (ddd, 
2JFF=267.5, 3JFF=13.4, 3JFF=10.5 Hz, Fβ) ppm. MS (ESI+) (m/z) 220 (M+H)+. HRMS (MS+) for 
C6H10F4NO3 (M + H)+ calcd 220.0591, found 220.0596. 
Supporting information General information, copies of 1H, 13C, and 19F NMR spectra of all 
compounds, and HMBC spectra of 7 and 8. 
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